See the article here: VistaGen Therapeutics Announces Pricing of Underwritten Public Offering
See the article here: VistaGen Therapeutics Announces Pricing of Underwritten Public Offering
Read more: Admission to Trading on Euronext Brussels
Visit link: Novozymes acquires Microbiome Labs
More: Inivata’s Liquid Biopsy Technology Included in Unique £10m Research Collaboration for Early Detection of Lung Cancer
Continued here: COVID-19 Clinical Programme Update
See the article here: EyePoint Pharmaceuticals Announces $16.5 Million Monetization of ILUVIEN® Royalty with SWK Holdings Corporation
Continue reading here: Oyster Point Pharma Submits New Drug Application to the U.S. Food and Drug Administration for OC-01 (varenicline) Nasal Spray for the Treatment of...
View original post here: Novartis receives complete response letter from U.S. FDA for inclisiran
Read the rest here: Myovant Sciences Announces FDA Approval of ORGOVYX™ (relugolix), the First and Only Oral Gonadotropin-Releasing Hormone (GnRH) Receptor Antagonist...
Read the original post: ProQR Announces Webcast of Presentation at Upcoming HC Wainwright BIOCONNECT Conference
Recent Comments